LPL Financial
DNTH icon

LPL Financial’s Dianthus Therapeutics DNTH Stock Holding History

LPL Financial’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.85M Buy
77,844
+12,549
+19% +$1.3M ﹤0.01% 2538
2026
Q2 		$6.37M Buy
65,295
+24,471
+60% +$2.14M ﹤0.01% 2572
2026
Q1 		$3.43M Buy
+40,824
New +$2.36M ﹤0.01% 2982

Other funds holding DNTH

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

LPL Financial's DNTH Position: Q3 2026 in Review

LPL Financial increased its Dianthus Therapeutics (DNTH) stake by 19% in Q3 2026, buying an estimated $1.3M and bringing the position to 77,844 shares worth $6.85M. The position accounts for ﹤0.01% of the portfolio, ranked #2538.

LPL Financial first reported a position in DNTH in Q1 2026 and has held it in 3 quarters since. 77 funds tracked by Wall St. Rank hold DNTH as of Q3 2026.

  • LPL Financial held 77,844 shares of Dianthus Therapeutics worth $6.85M as of Q3 2026.
  • LPL Financial bought 12,549 Dianthus Therapeutics shares in Q3 2026, an estimated $1.3M.
  • Dianthus Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q3 2026, its #2538 holding.
  • LPL Financial first reported a position in Dianthus Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • 77 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2026.

Based on LPL Financial's 13F filing for Q3 2026, filed 6 Nov 2026.